Advent Pharma Ltd.
Advent Pharma Ltd., a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and has established a significant presence across various operational regions. Founded in 2004, the company has achieved notable milestones, positioning itself as a trusted provider of high-quality medicines and healthcare solutions. Specialising in the development and manufacturing of generic pharmaceuticals, Advent Pharma offers a diverse portfolio that includes formulations for chronic and acute conditions. Their commitment to innovation and quality sets them apart in a competitive market, ensuring that they meet the evolving needs of healthcare professionals and patients alike. With a strong focus on research and development, Advent Pharma Ltd. has garnered recognition for its contributions to the industry, solidifying its market position as a reliable source of effective and affordable medications.
DitchCarbon Score
How does Advent Pharma Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Advent Pharma Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Advent Pharma Ltd.'s reported carbon emissions
Advent Pharma Ltd., headquartered in Bangladesh (BD), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Advent Pharma Ltd. may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific emissions data or commitments, it is unclear how Advent Pharma Ltd. aligns with these industry trends. As the company develops its sustainability strategy, it may consider adopting industry-standard climate terminology and frameworks, such as the Science Based Targets initiative (SBTi), to enhance its environmental accountability and transparency.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Advent Pharma Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
